INVEST: Abiomed -- too expensive?

From: Max More (
Date: Sat Feb 24 2001 - 15:17:20 MST

On the Extropians list, Dennis Ivey suggested Abiomed as a candidate for
extropic socially responsible investments.

Since then, I came across this bearish article on Abiomed by Herb Green of
The Street. Green is notoriously bearish, but is sometimes right (even when
I don't like it, as with LHSP). He warns about the high risk of Abiomed at
current prices:

I haven't examined this market, so I'm not taking a position, just
submitting this for your information.




Max More, Ph.D. or
President, Extropy Institute.
Senior Content Architect, ManyWorlds Inc.:

This archive was generated by hypermail 2b30 : Mon May 28 2001 - 09:56:47 MDT